SEC Form 4 · accession 0001104659-17-061574

RHYTHM PHARMACEUTICALS, INC. · RYTM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Oct 10, 2017

Accepted (ET)

Oct 10, 2017 · 4:22 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001649904

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Oct 10, 2017	C	45,831	—	A	645,161	I	The owner of record of the securities is Sutrepa SAS. Sutrepa SAS is controlled by Ipsen SA
Common Stock^F1	Oct 10, 2017	C	167,938	—	A	813,099	I	The owner of record of the securities is Sutrepa SAS. Sutrepa SAS is controlled by Ipsen SA
Common Stock	Oct 10, 2017	P	20,000	$17.00	A	833,099	I	The owner of record of the securities is Ipsen Pharma, S.A.S., which is controlled by Ipsen SA

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A-1 Junior Preferred Stock^F2,F1	—	Oct 10, 2017	C	45,831	D	—	—	Common Stock	45,831	0	I
Series A Convertible Preferred Stock^F2,F1	—	Oct 10, 2017	C	167,938	D	—	—	Common Stock	167,938	0	I

F1In connection with the closing of the Issuer's initial public offering, each share of the Issuer's series A convertible preferred stock (the "Series A Preferred") and series A-1 junior preferred stock (the "Series A-1 Preferred") converted into the Issuer's common stock on a 9.17-for-one basis without payment or consideration. The Series A Preferred and the Series A-1 Preferred had no expiration date.
F2Reflects the number of shares of Series A Preferred and Series A-1 Preferred, as applicable, held by the Reporting Person on an as-converted to common stock basis.